Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

COVID-19 × IMM-101 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 3 Pancreatic Neoplasms 2 Colorectal Neoplasms 2 Turcot syndrome 1 Neoplasms 1 COVID-19 1 Advanced Pancreatic Cancer 1

Interventions

Standard of Care 7 Surveys and Questionnaires 6 COVID-19 Vaccines 6 Blood Specimen Collection 6 Specimen Handling 5 BNT162 Vaccine 5 2019-nCoV Vaccine mRNA-1273 4 Practice Guidelines as Topic 3 Hydroxychloroquine 3 tocilizumab 2 sotrovimab 2 sinovac COVID-19 vaccine 2 cilgavimab and tixagevimab drug combination 2 Surgical Procedures, Operative 2 Pandemic Preparedness 2 Data Collection 2 CVnCoV COVID-19 vaccine 2 COH04S1 COVID-19 vaccine 2 Azithromycin 2 selinexor 1 remdesivir 1 regorafenib 1 proxalutamide 1 palbociclib 1 monalizumab 1 lenzilumab 1 heterologous prime boost COVID-19 vaccination 1 ciclesonide 1 bemcentinib 1 avdoralimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04442048 2025-12-30

COV-IMMUNO

Canadian Cancer Trials Group

Phase 3 Completed

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡